Robert Wang
Geriatric Medicine · Los Angeles, CANPI 1235293648
Payments from drug & device makers
Across 109 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanir Pharmaceuticals, Inc.$680
- Acadia Pharmaceuticals Inc$603
- Otsuka America Pharmaceutical, Inc.$294
- Harrow Eye, LLC$101
- Dexcom, Inc.$99
- Akebia Therapeutics Inc$81
- plus $506 from 17 others
What the payments were for
- Food & beverage$2,355100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 35 | $680 |
| Acadia Pharmaceuticals Inc | 32 | $603 |
| Otsuka America Pharmaceutical, Inc. | 12 | $294 |
| Harrow Eye, LLC | 1 | $101 |
| Dexcom, Inc. | 4 | $99 |
| Akebia Therapeutics Inc | 3 | $81 |
| AstraZeneca | 3 | $68 |
| IBSA Pharma Inc. | 2 | $40 |
| Eisai Inc. | 2 | $40 |
| Electromed, Inc. | 2 | $35 |
| Ardelyx, Inc. | 1 | $34 |
| Exact Sciences | 1 | $32 |
| Tanabe Pharma America, Inc. | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Amgen | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Pfizer | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$125
- ILEVRO$101
How this compares
$2,364 in reported general payments places this provider in the 85th percentile of 494 geriatric medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 26 | $36,201 |
| Invega SustennaPaliperidone Palmitate | 18 | $31,006 |
| EliquisApixaban | 45 | $30,984 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $19,442 |
| RexultiBrexpiprazole | 13 | $17,141 |
| EpogenEpoetin Alfa | 23 | $15,221 |
| OzempicSemaglutide | 17 | $14,002 |
| JanuviaSitagliptin Phosphate | 12 | $6,818 |
| Aripiprazole | 14 | $1,918 |
| Memantine Hcl | 40 | $1,703 |
| Amiodarone Hcl | 16 | $1,620 |
| Mirtazapine | 40 | $1,088 |
| Duloxetine Hcl | 23 | $1,072 |
| Clonazepam | 25 | $981 |
| Colchicine | 20 | $817 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $30,98445 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $680 | $19,44213 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $294 | $17,14113 claims |
| AmgenEpogen | $25 | $15,22123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 494 geriatric medicine providers in California.
Other geriatric medicine in Los Angeles
- Wayne ChenLos Angeles$2M
- Arman HekmatiLos Angeles$14K
- Dong LeeLos Angeles$7K
- Sylvia CarlisleLos Angeles$4K
- Joshua ChodoshLos Angeles$4K
- Azmy GhalyLos Angeles$4K
- Jo Ann PullenLos Angeles$3K
- Paul AisenSan Diego$15.7M
- Kanagaratnam SivalingamLancaster$2.4M
- Robert FeldmanLaguna Hills$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.